{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T03:10:22Z","timestamp":1794453022327,"version":"4.9.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T00:00:00Z","timestamp":1679011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T00:00:00Z","timestamp":1679011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["204841\/Z\/16\/Z"],"award-info":[{"award-number":["204841\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>A comprehensive evaluation of the total burden of morbidity endured by cancer survivors remains unavailable. This study quantified the burden of 144 health conditions and critical care admissions across 26 adult cancers and treatment modalities in 243,767 adults. By age 60, top conditions ranked by fold difference (cumulative burden in survivors divided by cumulative burden in controls) were haematology, immunology\/infection and pulmonary conditions. Patients who had all three forms of treatment (chemotherapy, radiotherapy and surgery) experienced a high cumulative burden of late morbidities compared with patients who received radiotherapy alone. The top five cancers with the highest cumulative burden of critical care admissions by age 60 were bone (12.4 events per 100 individuals [CI: 11.6-13.1]), brain (9.0 [7.5-10.5]), spinal cord and nervous system (7.2 [6.7-7.8]), testis (6.7 [4.9-8.4]) and Hodgkin lymphoma (4.4 [3.6-5.1]). Conditions that were associated with high excess years-of-life-lost were haematological conditions (9.6 years), pulmonary conditions (8.6 years) and immunological conditions or infections (7.8 years). As the population of cancer survivors continues to grow, our results indicate that it is important to tackle long-term health consequences through enacting data-driven policies.<\/jats:p>","DOI":"10.1038\/s41467-023-37231-3","type":"journal-article","created":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T19:58:59Z","timestamp":1679860739000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Cumulative burden of 144 conditions, critical care hospitalisation and premature mortality across 26 adult cancers"],"prefix":"10.1038","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5832-2000","authenticated-orcid":false,"given":"Wai Hoong","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard D.","family":"Neal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin D.","family":"Forster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8960-8095","authenticated-orcid":false,"given":"Alvina G.","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,17]]},"reference":[{"key":"37231_CR1","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1007\/s13187-016-0997-2","volume":"32","author":"C Marzorati","year":"2017","unstructured":"Marzorati, C., Riva, S. & Pravettoni, G. Who is a cancer survivor? A systematic review of published definitions. J. Cancer Educ. 32, 228\u2013237 (2017).","journal-title":"J. Cancer Educ."},{"key":"37231_CR2","unstructured":"European Cancer Patient Coalition. ESMO Patient Guide on Survivorship. https:\/\/ecpc.org\/policy\/survivorship\/."},{"key":"37231_CR3","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1093\/jamia\/ocz105","volume":"26","author":"S Denaxas","year":"2019","unstructured":"Denaxas, S. et al. UK phenomics platform for developing and validating electronic health record phenotypes: CALIBER. J. Am. Med. Inform. Assoc. 26, 1545\u20131559 (2019).","journal-title":"J. Am. Med. Inform. Assoc."},{"key":"37231_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12911-021-01638-z","volume":"21","author":"AG Lai","year":"2021","unstructured":"Lai, A. G. et al. An informatics consult approach for generating clinical evidence for treatment decisions. BMC Med. Inform. Decis. Mak. 21, 281 (2021).","journal-title":"BMC Med. Inform. Decis. Mak."},{"key":"37231_CR5","unstructured":"National Cancer Registration and Analysis Service. NCRAS Publications. http:\/\/www.ncin.org.uk\/publications\/."},{"key":"37231_CR6","doi-asserted-by":"publisher","first-page":"3889","DOI":"10.1093\/eurheartj\/ehz766","volume":"40","author":"KM Sturgeon","year":"2019","unstructured":"Sturgeon, K. M. et al. A population-based study of cardiovascular disease mortality risk in US cancer patients. Eur. Heart J. 40, 3889\u20133897 (2019).","journal-title":"Eur. Heart J."},{"key":"37231_CR7","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1001\/jama.2010.1449","volume":"304","author":"CS Sima","year":"2010","unstructured":"Sima, C. S., Panageas, K. S. & Schrag, D. Cancer screening among patients with advanced cancer. Jama 304, 1584\u20131591 (2010).","journal-title":"Jama"},{"key":"37231_CR8","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ijcard.2019.01.082","volume":"281","author":"G Tini","year":"2019","unstructured":"Tini, G. et al. Arterial hypertension in cancer: the elephant in the room. Int. J. Cardiol. 281, 133\u2013139 (2019).","journal-title":"Int. J. Cardiol."},{"key":"37231_CR9","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1161\/CIRCULATIONAHA.121.055329","volume":"144","author":"JA Blumenthal","year":"2021","unstructured":"Blumenthal, J. A. et al. Effects of lifestyle modification on patients with resistant hypertension: results of the TRIUMPH randomized clinical trial. Circulation 144, 1212\u20131226 (2021).","journal-title":"Circulation"},{"key":"37231_CR10","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.urology.2006.11.002","volume":"69","author":"J Morote","year":"2007","unstructured":"Morote, J. et al. Prevalence of osteoporosis during long-term androgen deprivation therapy in patients with prostate cancer. Urology 69, 500\u2013504 (2007).","journal-title":"Urology"},{"key":"37231_CR11","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJMoa1404037","volume":"371","author":"O Pagani","year":"2014","unstructured":"Pagani, O. et al. Adjuvant exemestane with ovarian suppression in premenopausal breast cancer. N. Engl. J. Med. 371, 107\u2013118 (2014).","journal-title":"N. Engl. J. Med."},{"key":"37231_CR12","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1093\/annonc\/mdp033","volume":"20","author":"M Rabaglio","year":"2009","unstructured":"Rabaglio, M. et al. Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial. Ann. Oncol. 20, 1489\u20131498 (2009).","journal-title":"Ann. Oncol."},{"key":"37231_CR13","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1200\/JCO.1997.15.4.1341","volume":"15","author":"T Saarto","year":"1997","unstructured":"Saarto, T. et al. Chemical castration induced by adjuvant cyclophosphamide, methotrexate, and fluorouracil chemotherapy causes rapid bone loss that is reduced by clodronate: a randomized study in premenopausal breast cancer patients. J. Clin. Oncol. 15, 1341\u20131347 (1997).","journal-title":"J. Clin. Oncol."},{"key":"37231_CR14","doi-asserted-by":"publisher","first-page":"587","DOI":"10.3389\/fendo.2019.00587","volume":"10","author":"S Costa","year":"2019","unstructured":"Costa, S. & Reagan, M. R. Therapeutic irradiation: consequences for bone and bone marrow adipose tissue. Front. Endocrinol. 10, 587 (2019).","journal-title":"Front. Endocrinol."},{"key":"37231_CR15","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1200\/JCO.2005.02.7102","volume":"25","author":"MF Gnant","year":"2007","unstructured":"Gnant, M. F. et al. Zoledronic acid effectively prevents cancer treatment-induced bone loss in premenopausal women receiving adjuvant endocrine therapy for hormone-responsive breast cancer: a report from the Austrian Breast and Colorectal Cancer Study Group. J. Clin. Oncol. 25, 820\u2013828 (2007).","journal-title":"J. Clin. Oncol."},{"key":"37231_CR16","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1038\/bjc.2012.366","volume":"107","author":"J Maddams","year":"2012","unstructured":"Maddams, J., Utley, M. & M\u00f8ller, H. Projections of cancer prevalence in the United Kingdom, 2010-\u22122040. Br. J. Cancer 107, 1195\u20131202 (2012).","journal-title":"Br. J. Cancer"},{"key":"37231_CR17","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1016\/S0140-6736(17)31610-0","volume":"390","author":"N Bhakta","year":"2017","unstructured":"Bhakta, N. et al. The cumulative burden of surviving childhood cancer: an initial report from the St Jude Lifetime Cohort Study (SJLIFE). Lancet 390, 2569\u20132582 (2017).","journal-title":"Lancet"},{"key":"37231_CR18","doi-asserted-by":"publisher","first-page":"100248","DOI":"10.1016\/j.lanepe.2021.100248","volume":"12","author":"WH Chang","year":"2021","unstructured":"Chang, W. H. et al. Late effects of cancer in children, teenagers and young adults: population-based study on the burden of 183 conditions, in-patient and critical care admissions and years of life lost. Lancet Regional Health Eur. 12, 100248 (2021).","journal-title":"Lancet Regional Health Eur."},{"key":"37231_CR19","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/S1470-2045(16)30215-7","volume":"17","author":"N Bhakta","year":"2016","unstructured":"Bhakta, N. et al. Cumulative burden of cardiovascular morbidity in paediatric, adolescent, and young adult survivors of Hodgkin\u2019s lymphoma: an analysis from the St Jude Lifetime Cohort Study. lancet Oncol. 17, 1325\u20131334 (2016).","journal-title":"lancet Oncol."},{"key":"37231_CR20","unstructured":"Department of Health and Social Care. Living With and Beyond Cancer: Taking Action to Improve Outcomes. https:\/\/www.gov.uk\/government\/publications\/living-with-and-beyond-cancer-taking-action-to-improve-outcomes."},{"key":"37231_CR21","doi-asserted-by":"publisher","first-page":"e234","DOI":"10.3399\/bjgp09X453567","volume":"59","author":"RA Lewis","year":"2009","unstructured":"Lewis, R. A. et al. Follow-up of cancer in primary care versus secondary care: systematic review. Br. J. Gen. Pract. 59, e234\u2013e247 (2009).","journal-title":"Br. J. Gen. Pract."},{"key":"37231_CR22","unstructured":"National Institute for Health and Care Excellence. Prostate cancer: diagnosis and management. https:\/\/www.nice.org.uk\/guidance\/ng131\/chapter\/Recommendations."},{"key":"37231_CR23","doi-asserted-by":"publisher","first-page":"e12903","DOI":"10.1111\/ecc.12903","volume":"28","author":"ME Stegmann","year":"2019","unstructured":"Stegmann, M. E. et al. Correspondence between primary and secondary care about patients with cancer: a qualitative mixed-methods analysis. Eur. J. Cancer Care 28, e12903 (2019).","journal-title":"Eur. J. Cancer Care"},{"key":"37231_CR24","doi-asserted-by":"publisher","first-page":"e997","DOI":"10.1161\/CIR.0000000000000679","volume":"139","author":"SC Gilchrist","year":"2019","unstructured":"Gilchrist, S. C. et al. Circulation 139, e997\u2013e1012 (2019). Cardio-oncology rehabilitation to manage cardiovascular outcomes in cancer patients and survivors: a scientific statement from the American Heart Association.","journal-title":"Circulation"},{"key":"37231_CR25","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1200\/JCO.2016.70.5400","volume":"35","author":"SH Armenian","year":"2017","unstructured":"Armenian, S. H. et al. Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American Society of Clinical Oncology Clinical Practice Guideline. J. Clin. Oncol. 35, 893\u2013911 (2017).","journal-title":"J. Clin. Oncol."},{"key":"37231_CR26","doi-asserted-by":"publisher","first-page":"e0234389","DOI":"10.1371\/journal.pone.0234389","volume":"15","author":"TP Miguel","year":"2020","unstructured":"Miguel, T. P. et al. Chemoradiation for cervical cancer treatment portends high risk of pelvic floor dysfunction. PLoS ONE 15, e0234389 (2020).","journal-title":"PLoS ONE"},{"key":"37231_CR27","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1093\/aje\/kwu289","volume":"181","author":"H Dong","year":"2015","unstructured":"Dong, H. et al. Estimating the burden of recurrent events in the presence of competing risks: The method of mean cumulative count. Am. J. Epidemiol. 181, 532\u2013540 (2015).","journal-title":"Am. J. Epidemiol."},{"key":"37231_CR28","unstructured":"American Cancer Society. Cancer treatment and survivorship facts and figures 2019\u20132021. Am. Cancer Soc. 1\u201348 (2019)."},{"key":"37231_CR29","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3322\/caac.21548","volume":"69","author":"CM Alfano","year":"2019","unstructured":"Alfano, C. M. et al. Equitably improving outcomes for cancer survivors and supporting caregivers: a blueprint for care delivery, research, education, and policy. Cancer J. Clin. 69, 35\u201349 (2019).","journal-title":"Cancer J. Clin."},{"key":"37231_CR30","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.1002\/cncr.31389","volume":"124","author":"CC Murphy","year":"2018","unstructured":"Murphy, C. C. et al. Polypharmacy and patterns of prescription medication use among cancer survivors. Cancer 124, 2850\u20132857 (2018).","journal-title":"Cancer"},{"key":"37231_CR31","doi-asserted-by":"publisher","first-page":"e63","DOI":"10.1016\/S2589-7500(19)30012-3","volume":"1","author":"V Kuan","year":"2019","unstructured":"Kuan, V. et al. A chronological map of 308 physical and mental health conditions from 4 million individuals in the English National Health Service. Lancet Digital Health 1, e63\u2013e77 (2019).","journal-title":"Lancet Digital Health"},{"key":"37231_CR32","doi-asserted-by":"publisher","first-page":"e043828","DOI":"10.1136\/bmjopen-2020-043828","volume":"10","author":"AG Lai","year":"2020","unstructured":"Lai, A. G. et al. Estimated impact of the COVID-19 pandemic on cancer services and excess 1-year mortality in people with cancer and multimorbidity: near real-time data on cancer care, cancer deaths and a population-based cohort study. BMJ Open 10, e043828 (2020).","journal-title":"BMJ Open"},{"key":"37231_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-021-03210-9","volume":"20","author":"WH Chang","year":"2022","unstructured":"Chang, W. H., Mueller, S. H., Chung, S.-C., Foster, G. R. & Lai, A. G. Increased burden of cardiovascular disease in people with liver disease: unequal geographical variations, risk factors and excess years of life lost. J. Transl. Med. 20, 1\u201313 (2022).","journal-title":"J. Transl. Med."},{"key":"37231_CR34","doi-asserted-by":"publisher","first-page":"e0228073","DOI":"10.1371\/journal.pone.0228073","volume":"15","author":"O Plana-Ripoll","year":"2020","unstructured":"Plana-Ripoll, O. et al. lillies: An R package for the estimation of excess Life Years Lost among patients with a given disease or condition. PLoS ONE 15, e0228073 (2020).","journal-title":"PLoS ONE"},{"key":"37231_CR35","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/S2215-0366(17)30429-7","volume":"4","author":"A Erlangsen","year":"2017","unstructured":"Erlangsen, A. et al. Cause-specific life-years lost in people with mental disorders: a nationwide, register-based cohort study. Lancet Psychiatry 4, 937\u2013945 (2017).","journal-title":"Lancet Psychiatry"},{"key":"37231_CR36","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1016\/S0140-6736(19)32316-5","volume":"394","author":"O Plana-Ripoll","year":"2019","unstructured":"Plana-Ripoll, O. et al. A comprehensive analysis of mortality-related health metrics associated with mental disorders: a nationwide, register-based cohort study. Lancet 394, 1827\u20131835 (2019).","journal-title":"Lancet"},{"key":"37231_CR37","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.schres.2018.11.003","volume":"206","author":"TM Laursen","year":"2019","unstructured":"Laursen, T. M. et al. Cause-specific life years lost among persons diagnosed with schizophrenia: is it getting better or worse? Schizophr. Res. 206, 284\u2013290 (2019).","journal-title":"Schizophr. Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-37231-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-37231-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-37231-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T19:59:32Z","timestamp":1679860772000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-37231-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,17]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["37231"],"URL":"https:\/\/doi.org\/10.1038\/s41467-023-37231-3","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,17]]},"assertion":[{"value":"21 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1484"}}